New Releases from NCBI BookshelfDaratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).​Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).